MLM Biologics Developing Wound Infection Prevention Device for Military
MLM Biologics Inc., a graduate company of Sid Martin Biotech, has been awarded nearly $1.5 million by the US Army to develop a device that prevents infection in battlefield wounds. The device will utilize MLM Biologic’s collagen processing and stabilization technologies. The focus is on preventing infection in complex, traumatic injuries in austere environments. The company plans to incorporate their proprietary technologies and proven anti-inflammatory and anti-microbial components, with potential civilian use in the future.
CEOs Discuss Sid Martin Biotech’s Impact on Their Business Success
For the past 25 years, UF Innovate | Sid Martin Biotech has provided the foundation that has turned many startup companies into successful businesses. For many CEOs, Sid Martin played a fundamental role in keeping their companies alive during their infant stages. Gary Ascani is a former CEO of Banyan Biomarkers, Inc., a biotechnology company […]